OOIR: Observatory of International Research

Papers

(The H4-Index of Molecular Diagnosis & Therapy is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
ADORA3: A Key Player in the Pathogenesis of Intracranial Aneurysms and a Potential Diagnostic Biomarker	143
The Role of MicroRNAs in the Pathogenesis and as Biomarkers for Pediatric Epilepsy: A Systematic Review	85
Predictive Ability of Serum Amino Acid Levels to Differentiate Fibromyalgia Patients from Healthy Subjects	62
Marnetegragene Autotemcel: First Approval	61
Comment on “Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta‑Analysis”	60
Indirect Clinical Validation of a Programmed Death-Ligand 1 Laboratory-Developed Test for Gastric/Gastroesophageal Junction Adenocarcinoma with 22C3 Antibody Concentrate	43
Considering Tumour Sidedness is Critical for Accurate Interpretation of Liquid Biopsy Results in Metastatic Colorectal Cancer	43
Gene Therapy for Cardiomyocyte Renewal: Cell Cycle, a Potential Therapeutic Target	43
Personalized Cancer Monitoring Assay for the Detection of ctDNA in Patients with Solid Tumors	41
Expression Signature of Immune-Related MicroRNAs in Autoimmune Skin Disease: Psoriasis and Vitiligo Insights	40
Evaluation of Minimal Residual Disease in Patients with Neuroblastoma	37
Personalized Medicine in Cystic Fibrosis: Characterization of Eight Rare CFTR Variants in Intestinal Organoids and Cellular Models	35
FAPI-Targeted Molecular Imaging: Transforming Insights into Post-Ischemic Myocardial Remodeling?	35
The Role of Non-coding RNAs in Connective Tissue Diseases: Diagnostic and Therapeutic Potential of miRNAs, lncRNAs and circRNAs	34
Prediction of Biomarker Expression on Primary Pancreatic Ductal Adenocarcinoma Tissues Using Fine-Needle Biopsies: Paving the Way for a Patient-Tailored Molecular Imaging Approach	34
Research Progress on Signal Conversion Based on Aptamer Combined CRISPR/Cas System in Biosensors	32
Drug Hypersensitivity Reactions in Patients with Cystic Fibrosis: Potential Value of the Lymphocyte Toxicity Assay to Assess Risk	30
Correction to: Revakinagene Taroretcel: First Approval	27
Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders	27
Personalizing Oncolytic Immunovirotherapy Approaches	26
Fatty Acid Desaturase: The Yin or Yang of Disease Pathology	26
Advances and Challenges in the Diagnosis of Leishmaniasis	25
Development of a Nomogram to Predict Therapeutic Resistance in Metastatic Melanoma Using Longitudinal ctDNA Kinetics	25
Inflammatory Gene Panel Guiding the Study of Genetics in Inflammatory Bowel Disease	24